FAQ/Help |
Calendar |
Search |
Today's Posts |
03-16-2016, 08:39 PM | #1 | |||
|
||||
Senior Member
|
"...Researchers have long believed that it is the presence of the Lewy bodies that induces toxicity, and now discover that toxicity arises at an earlier level..."
http://parkinsonsnewstoday.com/2016/...lein-toxicity/
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
03-17-2016, 11:46 AM | #2 | ||
|
|||
Senior Member
|
Olsen, thanks for posting this. I think it is an important result. If it is confirmed, it will force a change of direction for much on-going research.
As I understand it, one of the leading contenders to explain PD was that in PwP alpha-synuclein formed fibrils and these aggregated together to form Lewy Bodies. It followed that a potential therapy could involve taking substances such as mannitol, curcumin and cumin which reduce the rate of alpha-synuclein fibrillation. The present finding shows that the situation is more complex than simple alpha-synuclein is good, while complex alpha-synuclein is bad. This finding is a set-back, because it shows that we do not understand the pathogenesis of the disease. I've been supplementing my normal diet with turmeric and cumin seeds in the hope that this would slow the fibrillation and, hence, the progression of the disease. Now is time for a rethink, John
__________________
Born 1955. Diagnosed PD 2005. Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg |
||
Reply With Quote |
03-17-2016, 01:54 PM | #3 | ||
|
|||
Junior Member
|
If this study is valid, then use of monoclonal antibodies like Prothena's PRX002 or another from Affiris Inc. would be the way to go. These vaccines remove soluble α-synuclein which is supposedly toxic to cells. On the other hand this new finding makes me feel more cautious in choosing experimental or non-proven therapies - too much uncertainty and unknown about the mechanisms involved into the pathogenesis of the disease. Even supplements most of us are taking could be questioned, as John mentioned in his post (assuming they work). I also recall that I saw some additional infos suggesting that soluble α-syn is a main offender.
|
||
Reply With Quote |
03-17-2016, 03:05 PM | #4 | ||
|
|||
Member
|
There have been posts here on Nilotnlib earlier. This is an FDA approved drug for cancer and it has been shown to work, at lower doses, for PD to clear out c-Abl activity. Does Michael Fox know about this?
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease http://www.nature.com/articles/srep04874#f7 https://gumc.georgetown.edu/news/Can...Clinical-Trial http://www.georgetown.edu/news/cance...ons-study.html http://lctglobal.com/upload/news/201...ns%20trial.pdf |
||
Reply With Quote |
03-21-2016, 01:53 PM | #5 | ||
|
|||
Member
|
Quote:
http://parkinsonsnewstoday.com/2016/...ase-treatment/ |
||
Reply With Quote |
03-21-2016, 01:57 PM | #6 | ||
|
|||
Member
|
[QUOTE=ashleyk;1204806]There have been posts here on Nilotnlib earlier. This is an FDA approved drug for cancer and it has been shown to work, at lower doses, for PD to clear out c-Abl activity. Does Michael Fox know about this?
Yes, MJFF knows about this small trial, as do all of the other major funding organizations and most people in the PD community. Unfortunately, with all of the publicity this trial received, the research team has yet to secure funding to begin a larger, controlled, phase 2 study. I have heard any number of reasons for the lack of interest and $, but who knows what the truth really is. |
||
Reply With Quote |
"Thanks for this!" says: |
03-21-2016, 09:21 PM | #7 | ||
|
|||
Member
|
[QUOTE=Tupelo3;1205347]
Quote:
http://neurotalk.psychcentral.com/ar.../t-220156.html |
||
Reply With Quote |
"Thanks for this!" says: | GerryW (03-22-2016) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Too much or too little alpha-synuclein | Parkinson's Disease | |||
Lewy bodies are not the primary cause of cell death in PD | Parkinson's Disease | |||
Dementia with Lewy-Bodies (DLB) | Dementia | |||
NEWS: Research to look at reasons for the formation of Lewy bodies | Parkinson's Disease | |||
Personality test could help doctors detect dementia with Lewy bodies | Parkinson's Disease |